Clinical Trial Update: Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC

View source ↗

Summary

Clinical trial update noting completion of a study evaluating the combination of ivosidenib (TIBSOVO) with azacitidine in acute myeloid leukemia, in line with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tibsovo (ivosidenib)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: iOMEDICO AG | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED